Company: PTPI
Filing Date: 2025-02-21
Form Type: 8-K
Source: 0001104659-25-016181
Chunk: 2

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-21
Form: 8-K
Item: Item 1.01
Chunk 2
---
-1 (File No. 333-284495), as amended, originally filed on January 24, 2025, and declared effective by
the U. S. Securities and Exchange Commission on February 14, 2025, and an additional registration statement on Form S-1 (No. 333-285005)
filed on February 14, 2025, pursuant to Rule 462(b) as promulgated under the Securities Act of 1933, as amended.

The Engagement Letter and the Purchase Agreement
contain customary representations and warranties, agreements and obligations, conditions to closing and termination provisions for similar
transactions. The foregoing descriptions of terms and conditions of the Purchase Agreement, the Pre-Funded Warrants and the Warrants,
do not purport to be complete and are qualified in their entirety by the full text of the form of the Purchase Agreement, the form of
the Pre-Funded Warrant, the form of the Series A Warrant and the form of the Series B Warrant, which are attached hereto as
Exhibits 10.1, 4.1, 4.2, and 4.3, respectively.

Item 8.01 Other Events.